Resistance	NN	B-NP	O	Other	###	1	Resistance	Resistance	NN	NN	_	0	root	_	_
to	TO	B-PP	O	Other	###	2	to	to	TO	TO	_	4	case	_	_
IL-10	NN	B-NP	B-protein	B-Protein	###	3	IL-10	IL-10	NN	NN	_	4	compound	_	_
inhibition	NN	I-NP	O	Other	###	4	inhibition	inhibition	NN	NN	_	1	nmod	_	_
of	IN	B-PP	O	Other	###	5	of	of	IN	IN	_	7	case	_	_
IFN-gamma	NN	B-NP	B-protein	B-Protein	###	6	IFN-gamma	IFN-gamma	NN	NN	_	7	compound	_	_
production	NN	I-NP	O	Other	###	7	production	production	NN	NN	_	4	nmod	_	_
in	IN	B-PP	O	Other	###	8	in	in	IN	IN	_	10	case	_	_
RA	NN	B-NP	B-cell_line	Other	###	9	RA	RA	NN	NN	_	10	compound	_	_
CD4	NN	B-NP	B-protein	B-Protein	###	10	CD4	CD4	NN	NN	_	7	nmod	_	_
+	+	O	O	Other	###	11	+	+	+	+	_	10	cc	_	_
T	NN	I-NP	I-cell_line	Other	###	12	T	T	NN	NN	_	10	conj	_	_
cells	NNS	I-NP	I-cell_line	Other	###	13	cells	cells	NNS	NNS	_	10	conj	_	_

The	DT	B-NP	O	Other	###	1	The	The	DT	DT	_	4	det	_	_
CD28	NN	I-NP	B-protein	B-Protein	###	2	CD28	CD28	NN	NN	_	4	compound	_	_
costimulatory	JJ	I-NP	O	Other	###	3	costimulatory	costimulatory	JJ	JJ	_	4	amod	_	_
pathway	NN	I-NP	O	Other	###	4	pathway	pathway	NN	NN	_	6	nsubj	_	_
is	VBZ	B-VP	O	Other	###	5	is	is	VBZ	VBZ	_	6	cop	_	_
crucial	JJ	B-ADJP	O	Other	###	6	crucial	crucial	JJ	JJ	_	0	root	_	_
for	IN	B-PP	O	Other	###	7	for	for	IN	IN	_	14	case	_	_
effective	JJ	B-NP	O	Other	###	8	effective	effective	JJ	JJ	_	14	amod	_	_
antigen	JJ	I-NP	O	Other	###	9	antigen	antigen	JJ	JJ	_	14	amod	_	_
-	-	O	O	Other	###	10	-	-	-	-	_	9	punct	_	_
specific	JJ	I-NP	O	Other	###	11	specific	specific	JJ	JJ	_	14	amod	_	_
T-cell	NN	I-NP	O	Other	###	12	T-cell	T-cell	NN	NN	_	14	compound	_	_
cytokine	NN	I-NP	O	Other	###	13	cytokine	cytokine	NN	NN	_	14	compound	_	_
production	NN	I-NP	O	Other	###	14	production	production	NN	NN	_	6	nmod	_	_
,	,	O	O	Other	###	15	,	,	,	,	_	6	punct	_	_
and	CC	O	O	Other	###	16	and	and	CC	CC	_	6	cc	_	_
IL-10	NN	B-NP	B-protein	B-Protein	###	17	IL-10	IL-10	NN	NN	_	20	nsubj	_	_
can	MD	B-VP	O	Other	###	18	can	can	MD	MD	_	20	aux	_	_
directly	RB	I-VP	O	Other	###	19	directly	directly	RB	RB	_	20	advmod	_	_
suppress	VB	I-VP	O	Other	###	20	suppress	suppress	VB	VB	_	6	conj	_	_
this	DT	B-NP	O	Other	###	21	this	this	DT	DT	_	22	det	_	_
response	NN	I-NP	O	Other	###	22	response	response	NN	NN	_	20	dobj	_	_
by	IN	B-PP	O	Other	###	23	by	by	IN	IN	_	24	mark	_	_
inhibiting	VBG	B-VP	O	Other	###	24	inhibiting	inhibiting	VBG	VBG	_	20	advcl	_	_
CD28	NN	B-NP	B-protein	B-Protein	###	25	CD28	CD28	NN	NN	_	27	compound	_	_
tyrosine	NN	I-NP	O	Other	###	26	tyrosine	tyrosine	NN	NN	_	27	compound	_	_
phosphorylation	NN	I-NP	O	Other	###	27	phosphorylation	phosphorylation	NN	NN	_	24	dobj	_	_
and	CC	O	O	Other	###	28	and	and	CC	CC	_	27	cc	_	_
binding	NN	B-NP	O	Other	###	29	binding	binding	NN	NN	_	27	conj	_	_
of	IN	B-PP	O	Other	###	30	of	of	IN	IN	_	32	case	_	_
phosphatidylinositol	NN	B-NP	B-protein	Other	###	31	phosphatidylinositol	phosphatidylinositol	NN	NN	_	32	compound	_	_
3-kinase	NN	I-NP	I-protein	Other	###	32	3-kinase	3-kinase	NN	NN	_	29	nmod	_	_
[	(	O	O	Other	###	33	[	[	(	(	_	20	conj	_	_
24	CD	B-NP	O	Other	###	34	24	24	CD	CD	_	35	nummod	_	_
]	)	O	O	Other	###	35	]	]	)	)	_	33	xcomp	_	_
.	.	O	O	Other	###	36	.	.	.	.	_	6	punct	_	_

To	TO	B-VP	O	Other	###	1	To	To	TO	TO	_	2	mark	_	_
evaluate	VB	I-VP	O	Other	###	2	evaluate	evaluate	VB	VB	_	32	advcl	_	_
the	DT	B-NP	O	Other	###	3	the	the	DT	DT	_	4	det	_	_
responsiveness	NN	I-NP	O	Other	###	4	responsiveness	responsiveness	NN	NN	_	2	dobj	_	_
of	IN	B-PP	O	Other	###	5	of	of	IN	IN	_	7	case	_	_
RA	NN	B-NP	B-cell_type	Other	###	6	RA	RA	NN	NN	_	7	compound	_	_
CD4	NN	B-NP	B-protein	B-Protein	###	7	CD4	CD4	NN	NN	_	4	nmod	_	_
+	+	O	O	Other	###	8	+	+	+	+	_	7	cc	_	_
T	NN	I-NP	I-cell_type	Other	###	9	T	T	NN	NN	_	10	compound	_	_
cells	NNS	I-NP	I-cell_type	Other	###	10	cells	cells	NNS	NNS	_	7	conj	_	_
to	TO	B-PP	O	Other	###	11	to	to	TO	TO	_	12	case	_	_
IL-10	NN	B-NP	B-protein	B-Protein	###	12	IL-10	IL-10	NN	NN	_	4	nmod	_	_
,	,	O	O	Other	###	13	,	,	,	,	_	32	punct	_	_
purified	VBN	B-NP	O	Other	###	14	purified	purified	VBN	VBN	_	16	amod	_	_
PB	NN	I-NP	B-cell_type	Other	###	15	PB	PB	NN	NN	_	16	compound	_	_
CD4	NN	B-NP	B-protein	B-Protein	###	16	CD4	CD4	NN	NN	_	32	nsubjpass	_	_
+	+	O	O	Other	###	17	+	+	+	+	_	16	cc	_	_
T	NN	I-NP	I-cell_type	Other	###	18	T	T	NN	NN	_	19	compound	_	_
cells	NNS	I-NP	I-cell_type	Other	###	19	cells	cells	NNS	NNS	_	16	conj	_	_
from	IN	B-PP	O	Other	###	20	from	from	IN	IN	_	22	case	_	_
three	CD	B-NP	O	Other	###	21	three	three	CD	CD	_	22	nummod	_	_
patients	NNS	I-NP	O	Other	###	22	patients	patients	NNS	NNS	_	16	nmod	_	_
with	IN	B-PP	O	Other	###	23	with	with	IN	IN	_	25	case	_	_
active	JJ	B-NP	O	Other	###	24	active	active	JJ	JJ	_	25	amod	_	_
RA	NN	I-NP	O	Other	###	25	RA	RA	NN	NN	_	22	nmod	_	_
and	CC	B-PP	O	Other	###	26	and	and	CC	CC	_	22	cc	_	_
from	IN	B-PP	O	Other	###	27	from	from	IN	IN	_	30	case	_	_
three	CD	B-NP	O	Other	###	28	three	three	CD	CD	_	30	nummod	_	_
healthy	JJ	I-NP	O	Other	###	29	healthy	healthy	JJ	JJ	_	30	amod	_	_
controls	NNS	I-NP	O	Other	###	30	controls	controls	NNS	NNS	_	22	conj	_	_
were	VBD	B-VP	O	Other	###	31	were	were	VBD	VBD	_	32	auxpass	_	_
stimulated	VBN	I-VP	O	Other	###	32	stimulated	stimulated	VBN	VBN	_	0	root	_	_
by	IN	B-PP	O	Other	###	33	by	by	IN	IN	_	38	case	_	_
immobilized	VBN	B-NP	O	Other	###	34	immobilized	immobilized	VBN	VBN	_	38	amod	_	_
anti	NN	B-NP	O	Other	###	35	anti	anti	NN	NN	_	38	compound	_	_
-	-	O	O	Other	###	36	-	-	-	-	_	38	punct	_	_
CD3	NN	B-NP	B-protein	B-Protein	###	37	CD3	CD3	NN	NN	_	38	compound	_	_
antibody	NN	I-NP	I-protein	Other	###	38	antibody	antibody	NN	NN	_	32	nmod	_	_
and	CC	O	O	Other	###	39	and	and	CC	CC	_	38	cc	_	_
anti	NN	B-NP	O	Other	###	40	anti	anti	NN	NN	_	43	compound	_	_
-	-	O	O	Other	###	41	-	-	-	-	_	40	punct	_	_
CD28	NN	B-NP	B-protein	B-Protein	###	42	CD28	CD28	NN	NN	_	43	compound	_	_
antibody	NN	I-NP	I-protein	Other	###	43	antibody	antibody	NN	NN	_	38	conj	_	_
with	IN	B-PP	O	Other	###	44	with	with	IN	IN	_	48	nmod	_	_
or	CC	B-PP	O	Other	###	45	or	or	CC	CC	_	48	cc	_	_
without	IN	B-PP	O	Other	###	46	without	without	IN	IN	_	48	conj	_	_
diluted	JJ	B-NP	O	Other	###	47	diluted	diluted	JJ	JJ	_	48	amod	_	_
concentrations	NNS	I-NP	O	Other	###	48	concentrations	concentrations	NNS	NNS	_	32	nmod	_	_
of	IN	B-PP	O	Other	###	49	of	of	IN	IN	_	50	case	_	_
IL-10	NN	B-NP	B-protein	B-Protein	###	50	IL-10	IL-10	NN	NN	_	48	nmod	_	_
for	IN	B-PP	O	Other	###	51	for	for	IN	IN	_	53	case	_	_
36	CD	B-NP	O	Other	###	52	36	36	CD	CD	_	53	nummod	_	_
hours	NNS	I-NP	O	Other	###	53	hours	hours	NNS	NNS	_	48	nmod	_	_
,	,	O	O	Other	###	54	,	,	,	,	_	32	punct	_	_
and	CC	O	O	Other	###	55	and	and	CC	CC	_	32	cc	_	_
IFN-gamma	NN	B-NP	B-protein	B-Protein	###	56	IFN-gamma	IFN-gamma	NN	NN	_	57	compound	_	_
production	NN	I-NP	O	Other	###	57	production	production	NN	NN	_	59	nsubjpass	_	_
was	VBD	B-VP	O	Other	###	58	was	was	VBD	VBD	_	59	auxpass	_	_
measured	VBN	I-VP	O	Other	###	59	measured	measured	VBN	VBN	_	32	conj	_	_
by	IN	B-PP	O	Other	###	60	by	by	IN	IN	_	61	case	_	_
ELISA	NN	B-NP	O	Other	###	61	ELISA	ELISA	NN	NN	_	59	nmod	_	_
.	.	O	O	Other	###	62	.	.	.	.	_	32	punct	_	_

As	IN	B-SBAR	O	Other	###	1	As	As	IN	IN	_	2	mark	_	_
shown	VBN	B-VP	O	Other	###	2	shown	shown	VBN	VBN	_	19	advcl	_	_
in	IN	B-PP	O	Other	###	3	in	in	IN	IN	_	4	case	_	_
Fig	NNP	B-NP	O	Other	###	4	Fig	Fig	NNP	NNP	_	2	nmod	_	_
.	.	O	O	Other	###	5	.	.	.	.	_	4	punct	_	_
1	CD	I-NP	O	Other	###	6	1	1	CD	CD	_	4	nummod	_	_
,	,	O	O	Other	###	7	,	,	,	,	_	19	punct	_	_
IFN-gamma	NN	B-NP	B-protein	B-Protein	###	8	IFN-gamma	IFN-gamma	NN	NN	_	9	compound	_	_
production	NN	I-NP	O	Other	###	9	production	production	NN	NN	_	19	nsubjpass	_	_
by	IN	B-PP	O	Other	###	10	by	by	IN	IN	_	13	case	_	_
activated	VBN	B-NP	B-cell_type	Other	###	11	activated	activated	VBN	VBN	_	13	amod	_	_
normal	JJ	I-NP	I-cell_type	Other	###	12	normal	normal	JJ	JJ	_	13	amod	_	_
CD4	NN	B-NP	B-protein	B-Protein	###	13	CD4	CD4	NN	NN	_	9	nmod	_	_
+	+	O	O	Other	###	14	+	+	+	+	_	13	cc	_	_
T	NN	I-NP	I-cell_type	Other	###	15	T	T	NN	NN	_	13	conj	_	_
cells	NNS	I-NP	I-cell_type	Other	###	16	cells	cells	NNS	NNS	_	13	dep	_	_
was	VBD	B-VP	O	Other	###	17	was	was	VBD	VBD	_	19	auxpass	_	_
mostly	RB	I-VP	O	Other	###	18	mostly	mostly	RB	RB	_	19	advmod	_	_
inhibited	VBN	I-VP	O	Other	###	19	inhibited	inhibited	VBN	VBN	_	0	root	_	_
at	IN	B-PP	O	Other	###	20	at	at	IN	IN	_	21	case	_	_
concentrations	NNS	B-NP	O	Other	###	21	concentrations	concentrations	NNS	NNS	_	19	nmod	_	_
as	RB	B-ADJP	O	Other	###	22	as	as	RB	RB	_	23	advmod	_	_
low	JJ	I-ADJP	O	Other	###	23	low	low	JJ	JJ	_	19	advmod	_	_
as	IN	B-PP	O	Other	###	24	as	as	IN	IN	_	26	case	_	_
1	CD	B-NP	O	Other	###	25	1	1	CD	CD	_	26	nummod	_	_
ng	NN	I-NP	O	Other	###	26	ng	ng	NN	NN	_	29	compound	_	_
/	/	O	O	Other	###	27	/	/	/	/	_	29	punct	_	_
ml	NN	I-NP	O	Other	###	28	ml	ml	NN	NN	_	29	compound	_	_
IL-10	NN	I-NP	B-protein	B-Protein	###	29	IL-10	IL-10	NN	NN	_	23	nmod	_	_
.	.	O	O	Other	###	30	.	.	.	.	_	19	punct	_	_

However	RB	B-ADVP	O	Other	###	1	However	However	RB	RB	_	9	advmod	_	_
,	,	O	O	Other	###	2	,	,	,	,	_	9	punct	_	_
RA	NN	B-NP	B-cell_line	Other	###	3	RA	RA	NN	NN	_	9	nsubj	_	_
CD4	NN	B-NP	B-protein	B-Protein	###	4	CD4	CD4	NN	NN	_	3	dep	_	_
+	+	O	O	Other	###	5	+	+	+	+	_	3	cc	_	_
T	NN	I-NP	I-cell_line	Other	###	6	T	T	NN	NN	_	7	compound	_	_
cells	NNS	I-NP	I-cell_line	Other	###	7	cells	cells	NNS	NNS	_	3	dep	_	_
were	VBD	B-VP	O	Other	###	8	were	were	VBD	VBD	_	9	cop	_	_
able	JJ	B-ADJP	O	Other	###	9	able	able	JJ	JJ	_	0	root	_	_
to	TO	B-VP	O	Other	###	10	to	to	TO	TO	_	11	mark	_	_
produce	VB	I-VP	O	Other	###	11	produce	produce	VB	VB	_	9	xcomp	_	_
significant	JJ	B-NP	O	Other	###	12	significant	significant	JJ	JJ	_	13	amod	_	_
amounts	NNS	I-NP	O	Other	###	13	amounts	amounts	NNS	NNS	_	11	dobj	_	_
of	IN	B-PP	O	Other	###	14	of	of	IN	IN	_	15	case	_	_
IFN-gamma	NN	B-NP	B-protein	B-Protein	###	15	IFN-gamma	IFN-gamma	NN	NN	_	13	nmod	_	_
in	IN	B-PP	O	Other	###	16	in	in	IN	IN	_	18	case	_	_
the	DT	B-NP	O	Other	###	17	the	the	DT	DT	_	18	det	_	_
presence	NN	I-NP	O	Other	###	18	presence	presence	NN	NN	_	11	nmod	_	_
of	IN	B-PP	O	Other	###	19	of	of	IN	IN	_	21	case	_	_
1	CD	B-NP	O	Other	###	20	1	1	CD	CD	_	21	nummod	_	_
ng	NN	I-NP	O	Other	###	21	ng	ng	NN	NN	_	18	nmod	_	_
/	/	O	O	Other	###	22	/	/	/	/	_	21	punct	_	_
ml	NN	I-NP	O	Other	###	23	ml	ml	NN	NN	_	24	compound	_	_
IL-10	NN	I-NP	B-protein	B-Protein	###	24	IL-10	IL-10	NN	NN	_	21	dep	_	_
,	,	O	O	Other	###	25	,	,	,	,	_	9	punct	_	_
and	CC	O	O	Other	###	26	and	and	CC	CC	_	9	cc	_	_
the	DT	B-NP	O	Other	###	27	the	the	DT	DT	_	28	dep	_	_
maximal	JJ	I-NP	O	Other	###	28	maximal	maximal	JJ	JJ	_	32	amod	_	_
but	CC	B-CONJP	O	Other	###	29	but	but	CC	CC	_	28	cc	_	_
not	RB	I-CONJP	O	Other	###	30	not	not	RB	RB	_	31	neg	_	_
complete	JJ	B-NP	O	Other	###	31	complete	complete	JJ	JJ	_	28	conj	_	_
inhibition	NN	I-NP	O	Other	###	32	inhibition	inhibition	NN	NN	_	36	nsubjpass	_	_
by	IN	B-PP	O	Other	###	33	by	by	IN	IN	_	34	case	_	_
IL-10	NN	B-NP	B-protein	B-Protein	###	34	IL-10	IL-10	NN	NN	_	28	nmod	_	_
was	VBD	B-VP	O	Other	###	35	was	was	VBD	VBD	_	36	auxpass	_	_
obtained	VBN	I-VP	O	Other	###	36	obtained	obtained	VBN	VBN	_	9	conj	_	_
at	IN	B-PP	O	Other	###	37	at	at	IN	IN	_	41	case	_	_
10-100	CD	B-NP	O	Other	###	38	10-100	10-100	CD	CD	_	41	nummod	_	_
ng	NN	I-NP	O	Other	###	39	ng	ng	NN	NN	_	41	compound	_	_
/	/	O	O	Other	###	40	/	/	/	/	_	41	punct	_	_
ml	NN	I-NP	O	Other	###	41	ml	ml	NN	NN	_	36	nmod	_	_
.	.	O	O	Other	###	42	.	.	.	.	_	9	punct	_	_

We	PRP	B-NP	O	Other	###	1	We	We	PRP	PRP	_	3	nsubj	_	_
thus	RB	B-ADVP	O	Other	###	2	thus	thus	RB	RB	_	3	advmod	_	_
compared	VBD	B-VP	O	Other	###	3	compared	compared	VBD	VBD	_	0	root	_	_
the	DT	B-NP	O	Other	###	4	the	the	DT	DT	_	5	det	_	_
levels	NNS	I-NP	O	Other	###	5	levels	levels	NNS	NNS	_	3	dobj	_	_
of	IN	B-PP	O	Other	###	6	of	of	IN	IN	_	8	case	_	_
IFN-gamma	NN	B-NP	B-protein	B-Protein	###	7	IFN-gamma	IFN-gamma	NN	NN	_	8	compound	_	_
production	NN	I-NP	O	Other	###	8	production	production	NN	NN	_	5	nmod	_	_
by	IN	B-PP	O	Other	###	9	by	by	IN	IN	_	13	case	_	_
CD4	NN	B-NP	B-protein	B-Protein	###	10	CD4	CD4	NN	NN	_	8	nmod	_	_
+	+	O	O	Other	###	11	+	+	+	+	_	10	cc	_	_
T	NN	I-NP	I-cell_type	Other	###	12	T	T	NN	NN	_	13	compound	_	_
cells	NNS	I-NP	I-cell_type	Other	###	13	cells	cells	NNS	NNS	_	10	conj	_	_
after	IN	B-PP	O	Other	###	14	after	after	IN	IN	_	18	case	_	_
CD3	NN	B-NP	B-protein	B-Protein	###	15	CD3	CD3	NN	NN	_	18	compound	_	_
and	CC	O	O	Other	###	16	and	and	CC	CC	_	15	cc	_	_
CD28	NN	B-NP	B-protein	B-Protein	###	17	CD28	CD28	NN	NN	_	15	conj	_	_
costimulation	NN	I-NP	O	Other	###	18	costimulation	costimulation	NN	NN	_	5	nmod	_	_
in	IN	B-PP	O	Other	###	19	in	in	IN	IN	_	21	case	_	_
the	DT	B-NP	O	Other	###	20	the	the	DT	DT	_	21	det	_	_
presence	NN	I-NP	O	Other	###	21	presence	presence	NN	NN	_	3	nmod	_	_
of	IN	B-PP	O	Other	###	22	of	of	IN	IN	_	27	case	_	_
1	CD	B-NP	O	Other	###	23	1	1	CD	CD	_	24	nummod	_	_
ng	NN	I-NP	O	Other	###	24	ng	ng	NN	NN	_	27	compound	_	_
/	/	O	O	Other	###	25	/	/	/	/	_	27	punct	_	_
ml	NN	I-NP	O	Other	###	26	ml	ml	NN	NN	_	27	compound	_	_
IL-10	NN	I-NP	B-protein	B-Protein	###	27	IL-10	IL-10	NN	NN	_	21	nmod	_	_
in	IN	B-PP	O	Other	###	28	in	in	IN	IN	_	30	case	_	_
RA	NN	B-NP	O	Other	###	29	RA	RA	NN	NN	_	30	compound	_	_
patients	NNS	I-NP	O	Other	###	30	patients	patients	NNS	NNS	_	27	nmod	_	_
with	IN	B-PP	O	Other	###	31	with	with	IN	IN	_	33	case	_	_
active	JJ	B-NP	O	Other	###	32	active	active	JJ	JJ	_	33	amod	_	_
disease	NN	I-NP	O	Other	###	33	disease	disease	NN	NN	_	30	nmod	_	_
(	(	O	O	Other	###	34	(	(	(	(	_	37	punct	_	_
multiple	JJ	B-NP	O	Other	###	35	multiple	multiple	JJ	JJ	_	37	amod	_	_
inflammatory	JJ	I-NP	O	Other	###	36	inflammatory	inflammatory	JJ	JJ	_	37	amod	_	_
joints	NNS	I-NP	O	Other	###	37	joints	joints	NNS	NNS	_	33	dep	_	_
,	,	O	O	Other	###	38	,	,	,	,	_	37	punct	_	_
CRP	NN	B-NP	B-protein	Other	###	39	CRP	CRP	NN	NN	_	41	compound	_	_
level	NN	I-NP	O	Other	###	40	level	level	NN	NN	_	41	compound	_	_
>	SYM	B-NP	O	Other	###	41	>	>	SYM	SYM	_	37	appos	_	_
/	/	O	O	Other	###	42	/	/	/	/	_	37	punct	_	_
=	SYM	B-NP	O	Other	###	43	=	=	SYM	SYM	_	37	dep	_	_
10	CD	B-NP	O	Other	###	44	10	10	CD	CD	_	45	nummod	_	_
mg	NN	I-NP	O	Other	###	45	mg	mg	NN	NN	_	43	dobj	_	_
/	/	O	O	Other	###	46	/	/	/	/	_	47	punct	_	_
l	NN	I-NP	O	Other	###	47	l	l	NN	NN	_	37	dep	_	_
)	)	O	O	Other	###	48	)	)	)	)	_	37	punct	_	_
and	CC	O	O	Other	###	49	and	and	CC	CC	_	33	cc	_	_
inactive	JJ	B-NP	O	Other	###	50	inactive	inactive	JJ	JJ	_	51	amod	_	_
disease	NN	I-NP	O	Other	###	51	disease	disease	NN	NN	_	33	conj	_	_
(	(	O	O	Other	###	52	(	(	(	(	_	51	punct	_	_
in	IN	B-PP	O	Other	###	53	in	in	IN	IN	_	54	case	_	_
remission	NN	B-NP	O	Other	###	54	remission	remission	NN	NN	_	51	nmod	_	_
,	,	O	O	Other	###	55	,	,	,	,	_	51	punct	_	_
CRP	NN	B-NP	B-protein	Other	###	56	CRP	CRP	NN	NN	_	57	compound	_	_
level	NN	I-NP	O	Other	###	57	level	level	NN	NN	_	64	nsubj	_	_
<	SYM	B-NP	O	Other	###	58	<	<	SYM	SYM	_	57	amod	_	_
10	CD	B-NP	O	Other	###	59	10	10	CD	CD	_	60	nummod	_	_
mg	NN	I-NP	O	Other	###	60	mg	mg	NN	NN	_	62	amod	_	_
/	/	O	O	Other	###	61	/	/	/	/	_	62	punct	_	_
l	NN	I-NP	O	Other	###	62	l	l	NN	NN	_	58	dep	_	_
)	)	O	O	Other	###	63	)	)	)	)	_	37	punct	_	_
[	(	O	O	Other	###	64	[	[	(	(	_	51	acl	_	_
26	CD	B-NP	O	Other	###	65	26	26	CD	CD	_	66	nummod	_	_
]	)	O	O	Other	###	66	]	]	)	)	_	64	dobj	_	_
and	CC	O	O	Other	###	67	and	and	CC	CC	_	66	cc	_	_
in	IN	B-PP	O	Other	###	68	in	in	IN	IN	_	70	case	_	_
healthy	JJ	B-NP	O	Other	###	69	healthy	healthy	JJ	JJ	_	70	amod	_	_
controls	NNS	I-NP	O	Other	###	70	controls	controls	NNS	NNS	_	64	nmod	_	_
.	.	O	O	Other	###	71	.	.	.	.	_	3	punct	_	_

There	EX	B-NP	O	Other	###	1	There	There	EX	EX	_	2	expl	_	_
were	VBD	B-VP	O	Other	###	2	were	were	VBD	VBD	_	0	root	_	_
no	DT	B-NP	O	Other	###	3	no	no	DT	DT	_	6	neg	_	_
statistically	RB	I-NP	O	Other	###	4	statistically	statistically	RB	RB	_	5	advmod	_	_
significant	JJ	I-NP	O	Other	###	5	significant	significant	JJ	JJ	_	6	amod	_	_
differences	NNS	I-NP	O	Other	###	6	differences	differences	NNS	NNS	_	2	nsubj	_	_
in	IN	B-PP	O	Other	###	7	in	in	IN	IN	_	9	case	_	_
IFN-gamma	NN	B-NP	B-protein	B-Protein	###	8	IFN-gamma	IFN-gamma	NN	NN	_	9	compound	_	_
production	NN	I-NP	O	Other	###	9	production	production	NN	NN	_	6	nmod	_	_
without	IN	B-PP	O	Other	###	10	without	without	IN	IN	_	11	case	_	_
IL-10	NN	B-NP	B-protein	B-Protein	###	11	IL-10	IL-10	NN	NN	_	9	nmod	_	_
among	IN	B-PP	O	Other	###	12	among	among	IN	IN	_	15	case	_	_
these	DT	B-NP	O	Other	###	13	these	these	DT	DT	_	15	det	_	_
three	CD	I-NP	O	Other	###	14	three	three	CD	CD	_	15	nummod	_	_
groups	NNS	I-NP	O	Other	###	15	groups	groups	NNS	NNS	_	2	nmod	_	_
(	(	O	O	Other	###	16	(	(	(	(	_	17	punct	_	_
Fig	NN	B-NP	B-protein	Other	###	17	Fig	Fig	NN	NN	_	15	dep	_	_
.	.	O	O	Other	###	18	.	.	.	.	_	17	punct	_	_
2a	NN	I-NP	I-protein	Other	###	19	2a	2a	NN	NN	_	17	appos	_	_
)	)	O	O	Other	###	20	)	)	)	)	_	17	punct	_	_
,	,	O	O	Other	###	21	,	,	,	,	_	2	punct	_	_
but	CC	O	O	Other	###	22	but	but	CC	CC	_	2	cc	_	_
the	DT	B-NP	O	Other	###	23	the	the	DT	DT	_	25	det	_	_
inhibitory	JJ	I-NP	O	Other	###	24	inhibitory	inhibitory	JJ	JJ	_	25	amod	_	_
effect	NN	I-NP	O	Other	###	25	effect	effect	NN	NN	_	33	nsubjpass	_	_
of	IN	B-PP	O	Other	###	26	of	of	IN	IN	_	27	case	_	_
IL-10	NN	B-NP	B-protein	B-Protein	###	27	IL-10	IL-10	NN	NN	_	25	nmod	_	_
on	IN	B-PP	O	Other	###	28	on	on	IN	IN	_	30	case	_	_
IFN-gamma	NN	B-NP	B-protein	B-Protein	###	29	IFN-gamma	IFN-gamma	NN	NN	_	30	compound	_	_
production	NN	I-NP	O	Other	###	30	production	production	NN	NN	_	25	nmod	_	_
was	VBD	B-VP	O	Other	###	31	was	was	VBD	VBD	_	33	auxpass	_	_
significantly	RB	I-VP	O	Other	###	32	significantly	significantly	RB	RB	_	33	advmod	_	_
limited	VBN	I-VP	O	Other	###	33	limited	limited	VBN	VBN	_	2	conj	_	_
in	IN	B-PP	O	Other	###	34	in	in	IN	IN	_	38	case	_	_
the	DT	B-NP	O	Other	###	35	the	the	DT	DT	_	38	det	_	_
active	JJ	I-NP	O	Other	###	36	active	active	JJ	JJ	_	38	amod	_	_
RA	NN	I-NP	O	Other	###	37	RA	RA	NN	NN	_	38	compound	_	_
group	NN	I-NP	O	Other	###	38	group	group	NN	NN	_	33	nmod	_	_
as	IN	B-PP	O	Other	###	39	as	as	IN	IN	_	40	mark	_	_
compared	VBN	B-PP	O	Other	###	40	compared	compared	VBN	VBN	_	33	advcl	_	_
with	IN	B-PP	O	Other	###	41	with	with	IN	IN	_	45	case	_	_
the	DT	B-NP	O	Other	###	42	the	the	DT	DT	_	45	det	_	_
inactive	JJ	I-NP	O	Other	###	43	inactive	inactive	JJ	JJ	_	45	amod	_	_
RA	NN	I-NP	O	Other	###	44	RA	RA	NN	NN	_	45	compound	_	_
group	NN	I-NP	O	Other	###	45	group	group	NN	NN	_	40	nmod	_	_
and	CC	O	O	Other	###	46	and	and	CC	CC	_	45	cc	_	_
healthy	JJ	B-NP	O	Other	###	47	healthy	healthy	JJ	JJ	_	48	amod	_	_
controls	NNS	I-NP	O	Other	###	48	controls	controls	NNS	NNS	_	45	conj	_	_
(	(	O	O	Other	###	49	(	(	(	(	_	51	punct	_	_
percentage	NN	B-NP	O	Other	###	50	percentage	percentage	NN	NN	_	51	compound	_	_
decrease	NN	I-NP	O	Other	###	51	decrease	decrease	NN	NN	_	33	dep	_	_
:	:	O	O	Other	###	52	:	:	:	:	_	51	punct	_	_
active	JJ	B-NP	O	Other	###	53	active	active	JJ	JJ	_	54	amod	_	_
RA	NN	I-NP	O	Other	###	54	RA	RA	NN	NN	_	51	dep	_	_
,	,	O	O	Other	###	55	,	,	,	,	_	54	punct	_	_
2.9	CD	B-NP	O	Other	###	56	2.9	2.9	CD	CD	_	59	nummod	_	_
+/-	CC	I-NP	O	Other	###	57	+/-	+/-	CC	CC	_	56	cc	_	_
14.4	CD	I-NP	O	Other	###	58	14.4	14.4	CD	CD	_	56	conj	_	_
%	NN	I-NP	O	Other	###	59	%	%	NN	NN	_	54	dep	_	_
;	:	O	O	Other	###	60	;	;	:	:	_	54	punct	_	_
inactive	JJ	B-NP	O	Other	###	61	inactive	inactive	JJ	JJ	_	62	amod	_	_
RA	NN	I-NP	O	Other	###	62	RA	RA	NN	NN	_	54	dep	_	_
,	,	O	O	Other	###	63	,	,	,	,	_	62	punct	_	_
45.6	CD	B-NP	O	Other	###	64	45.6	45.6	CD	CD	_	67	nummod	_	_
+/-	SYM	I-NP	O	Other	###	65	+/-	+/-	SYM	SYM	_	64	cc	_	_
14.4	CD	I-NP	O	Other	###	66	14.4	14.4	CD	CD	_	64	conj	_	_
%	NN	I-NP	O	Other	###	67	%	%	NN	NN	_	62	dep	_	_
;	:	O	O	Other	###	68	;	;	:	:	_	54	punct	_	_
controls	NNS	B-NP	O	Other	###	69	controls	controls	NNS	NNS	_	54	dep	_	_
,	,	O	O	Other	###	70	,	,	,	,	_	69	punct	_	_
65.8	CD	B-NP	O	Other	###	71	65.8	65.8	CD	CD	_	74	nummod	_	_
+/-	SYM	I-NP	O	Other	###	72	+/-	+/-	SYM	SYM	_	71	cc	_	_
7.9	CD	I-NP	O	Other	###	73	7.9	7.9	CD	CD	_	71	conj	_	_
%	NN	I-NP	O	Other	###	74	%	%	NN	NN	_	69	appos	_	_
)	)	O	O	Other	###	75	)	)	)	)	_	69	punct	_	_
(	(	O	O	Other	###	76	(	(	(	(	_	77	punct	_	_
Fig	NNP	B-NP	O	Other	###	77	Fig	Fig	NNP	NNP	_	69	appos	_	_
.	.	O	O	Other	###	78	.	.	.	.	_	77	punct	_	_
2b	NNP	I-NP	O	Other	###	79	2b	2b	NNP	NNP	_	69	appos	_	_
)	)	O	O	Other	###	80	)	)	)	)	_	77	punct	_	_
.	.	O	O	Other	###	81	.	.	.	.	_	2	punct	_	_

As	IN	B-PP	O	Other	###	1	As	As	IN	IN	_	3	case	_	_
a	DT	B-NP	O	Other	###	2	a	a	DT	DT	_	3	det	_	_
consequence	NN	I-NP	O	Other	###	3	consequence	consequence	NN	NN	_	13	nmod	_	_
,	,	O	O	Other	###	4	,	,	,	,	_	13	punct	_	_
CD4	NN	B-NP	B-protein	B-Protein	###	5	CD4	CD4	NN	NN	_	8	compound	_	_
+	+	O	O	Other	###	6	+	+	+	+	_	5	cc	_	_
T	NN	I-NP	I-cell_type	Other	###	7	T	T	NN	NN	_	5	conj	_	_
cells	NNS	I-NP	I-cell_type	Other	###	8	cells	cells	NNS	NNS	_	13	nsubj	_	_
from	IN	B-PP	O	Other	###	9	from	from	IN	IN	_	12	case	_	_
active	JJ	B-NP	O	Other	###	10	active	active	JJ	JJ	_	12	amod	_	_
RA	NN	I-NP	O	Other	###	11	RA	RA	NN	NN	_	12	compound	_	_
patients	NNS	I-NP	O	Other	###	12	patients	patients	NNS	NNS	_	8	nmod	_	_
produced	VBD	B-VP	O	Other	###	13	produced	produced	VBD	VBD	_	0	root	_	_
higher	JJR	B-NP	O	Other	###	14	higher	higher	JJR	JJR	_	15	amod	_	_
levels	NNS	I-NP	O	Other	###	15	levels	levels	NNS	NNS	_	13	dobj	_	_
of	IN	B-PP	O	Other	###	16	of	of	IN	IN	_	17	case	_	_
IFN-gamma	NN	B-NP	B-protein	B-Protein	###	17	IFN-gamma	IFN-gamma	NN	NN	_	15	nmod	_	_
in	IN	B-PP	O	Other	###	18	in	in	IN	IN	_	20	case	_	_
the	DT	B-NP	O	Other	###	19	the	the	DT	DT	_	20	det	_	_
presence	NN	I-NP	O	Other	###	20	presence	presence	NN	NN	_	13	nmod	_	_
of	IN	B-PP	O	Other	###	21	of	of	IN	IN	_	23	case	_	_
1	CD	B-NP	O	Other	###	22	1	1	CD	CD	_	23	nummod	_	_
ng	NN	I-NP	O	Other	###	23	ng	ng	NN	NN	_	20	nmod	_	_
/	/	O	O	Other	###	24	/	/	/	/	_	23	punct	_	_
ml	NN	I-NP	O	Other	###	25	ml	ml	NN	NN	_	26	compound	_	_
IL-10	NN	I-NP	B-protein	B-Protein	###	26	IL-10	IL-10	NN	NN	_	20	nmod	_	_
than	IN	B-SBAR	O	Other	###	27	than	than	IN	IN	_	28	dep	_	_
did	VBD	O	O	Other	###	28	did	did	VBD	VBD	_	13	advcl	_	_
normal	JJ	B-NP	B-cell_type	Other	###	29	normal	normal	JJ	JJ	_	30	amod	_	_
CD4	NN	B-NP	B-protein	B-Protein	###	30	CD4	CD4	NN	NN	_	28	nsubj	_	_
+	+	O	O	Other	###	31	+	+	+	+	_	30	cc	_	_
T	NN	I-NP	I-cell_type	Other	###	32	T	T	NN	NN	_	33	compound	_	_
cells	NNS	I-NP	I-cell_type	Other	###	33	cells	cells	NNS	NNS	_	30	conj	_	_
(	(	O	O	Other	###	34	(	(	(	(	_	35	punct	_	_
Fig	NN	B-NP	B-protein	Other	###	35	Fig	Fig	NN	NN	_	33	appos	_	_
.	.	O	O	Other	###	36	.	.	.	.	_	35	punct	_	_
2a	NN	I-NP	I-protein	Other	###	37	2a	2a	NN	NN	_	35	appos	_	_
)	)	O	O	Other	###	38	)	)	)	)	_	35	punct	_	_
.	.	O	O	Other	###	39	.	.	.	.	_	13	punct	_	_

In	IN	B-PP	O	Other	###	1	In	In	IN	IN	_	2	case	_	_
addition	NN	B-NP	O	Other	###	2	addition	addition	NN	NN	_	5	nmod	_	_
,	,	O	O	Other	###	3	,	,	,	,	_	5	punct	_	_
we	PRP	B-NP	O	Other	###	4	we	we	PRP	PRP	_	5	nsubj	_	_
compared	VBD	B-VP	O	Other	###	5	compared	compared	VBD	VBD	_	0	root	_	_
IL-2	NN	B-NP	B-protein	B-Protein	###	6	IL-2	IL-2	NN	NN	_	7	compound	_	_
production	NN	I-NP	O	Other	###	7	production	production	NN	NN	_	5	dobj	_	_
by	IN	B-PP	O	Other	###	8	by	by	IN	IN	_	12	case	_	_
CD4	NN	B-NP	B-protein	B-Protein	###	9	CD4	CD4	NN	NN	_	7	nmod	_	_
+	+	O	O	Other	###	10	+	+	+	+	_	9	cc	_	_
T	NN	I-NP	I-cell_type	Other	###	11	T	T	NN	NN	_	12	compound	_	_
cells	NNS	I-NP	I-cell_type	Other	###	12	cells	cells	NNS	NNS	_	9	conj	_	_
after	IN	B-PP	O	Other	###	13	after	after	IN	IN	_	17	case	_	_
CD3	NN	B-NP	B-protein	Other	###	14	CD3	CD3	NN	NN	_	17	compound	_	_
and	CC	O	O	Other	###	15	and	and	CC	CC	_	14	cc	_	_
CD28	NN	B-NP	B-protein	B-Protein	###	16	CD28	CD28	NN	NN	_	14	conj	_	_
costimulation	NN	I-NP	O	Other	###	17	costimulation	costimulation	NN	NN	_	5	nmod	_	_
in	IN	B-PP	O	Other	###	18	in	in	IN	IN	_	20	case	_	_
the	DT	B-NP	O	Other	###	19	the	the	DT	DT	_	20	det	_	_
presence	NN	I-NP	O	Other	###	20	presence	presence	NN	NN	_	5	nmod	_	_
of	IN	B-PP	O	Other	###	21	of	of	IN	IN	_	22	case	_	_
IL-10	NN	B-NP	B-protein	B-Protein	###	22	IL-10	IL-10	NN	NN	_	20	nmod	_	_
in	IN	B-PP	O	Other	###	23	in	in	IN	IN	_	26	case	_	_
active	JJ	B-NP	O	Other	###	24	active	active	JJ	JJ	_	26	amod	_	_
RA	NN	I-NP	O	Other	###	25	RA	RA	NN	NN	_	26	compound	_	_
patients	NNS	I-NP	O	Other	###	26	patients	patients	NNS	NNS	_	22	nmod	_	_
and	CC	B-PP	O	Other	###	27	and	and	CC	CC	_	26	cc	_	_
in	IN	B-PP	O	Other	###	28	in	in	IN	IN	_	30	case	_	_
healthy	JJ	B-NP	O	Other	###	29	healthy	healthy	JJ	JJ	_	30	amod	_	_
controls	NNS	I-NP	O	Other	###	30	controls	controls	NNS	NNS	_	26	conj	_	_
.	.	O	O	Other	###	31	.	.	.	.	_	5	punct	_	_

Similarly	RB	B-ADVP	O	Other	###	1	Similarly	Similarly	RB	RB	_	7	advmod	_	_
,	,	O	O	Other	###	2	,	,	,	,	_	7	punct	_	_
IL-2	NN	B-NP	B-protein	B-Protein	###	3	IL-2	IL-2	NN	NN	_	4	compound	_	_
production	NN	I-NP	O	Other	###	4	production	production	NN	NN	_	7	nsubjpass	_	_
was	VBD	B-VP	O	Other	###	5	was	was	VBD	VBD	_	7	auxpass	_	_
not	RB	I-VP	O	Other	###	6	not	not	RB	RB	_	7	neg	_	_
affected	VBN	I-VP	O	Other	###	7	affected	affected	VBN	VBN	_	0	root	_	_
by	IN	B-PP	O	Other	###	8	by	by	IN	IN	_	13	case	_	_
1	CD	B-NP	O	Other	###	9	1	1	CD	CD	_	10	nummod	_	_
ng	NN	I-NP	O	Other	###	10	ng	ng	NN	NN	_	13	compound	_	_
/	/	O	O	Other	###	11	/	/	/	/	_	10	punct	_	_
ml	NN	I-NP	O	Other	###	12	ml	ml	NN	NN	_	13	compound	_	_
IL-10	NN	I-NP	B-protein	B-Protein	###	13	IL-10	IL-10	NN	NN	_	7	nmod	_	_
in	IN	B-PP	O	Other	###	14	in	in	IN	IN	_	16	case	_	_
RA	NN	B-NP	O	Other	###	15	RA	RA	NN	NN	_	16	compound	_	_
patients	NNS	I-NP	O	Other	###	16	patients	patients	NNS	NNS	_	7	nmod	_	_
(	(	O	O	Other	###	17	(	(	(	(	_	19	punct	_	_
percentage	NN	B-NP	O	Other	###	18	percentage	percentage	NN	NN	_	19	compound	_	_
decrease	NN	I-NP	O	Other	###	19	decrease	decrease	NN	NN	_	7	dep	_	_
,	,	O	O	Other	###	20	,	,	,	,	_	19	punct	_	_
-2.1	CD	B-NP	O	Other	###	21	-2.1	-2.1	CD	CD	_	24	nummod	_	_
+/-	SYM	I-NP	O	Other	###	22	+/-	+/-	SYM	SYM	_	21	cc	_	_
13.8	CD	I-NP	O	Other	###	23	13.8	13.8	CD	CD	_	21	conj	_	_
%	NN	I-NP	O	Other	###	24	%	%	NN	NN	_	19	appos	_	_
)	)	O	O	Other	###	25	)	)	)	)	_	19	punct	_	_
,	,	O	O	Other	###	26	,	,	,	,	_	7	punct	_	_
while	IN	B-SBAR	O	Other	###	27	while	while	IN	IN	_	31	mark	_	_
it	PRP	B-NP	O	Other	###	28	it	it	PRP	PRP	_	31	nsubjpass	_	_
was	VBD	B-VP	O	Other	###	29	was	was	VBD	VBD	_	31	auxpass	_	_
significantly	RB	I-VP	O	Other	###	30	significantly	significantly	RB	RB	_	31	advmod	_	_
reduced	VBN	I-VP	O	Other	###	31	reduced	reduced	VBN	VBN	_	7	advcl	_	_
in	IN	B-PP	O	Other	###	32	in	in	IN	IN	_	34	case	_	_
healthy	JJ	B-NP	O	Other	###	33	healthy	healthy	JJ	JJ	_	34	amod	_	_
controls	NNS	I-NP	O	Other	###	34	controls	controls	NNS	NNS	_	31	nmod	_	_
(	(	O	O	Other	###	35	(	(	(	(	_	39	punct	_	_
61.1	CD	B-NP	O	Other	###	36	61.1	61.1	CD	CD	_	39	nummod	_	_
+/-	SYM	I-NP	O	Other	###	37	+/-	+/-	SYM	SYM	_	36	cc	_	_
13.7	CD	I-NP	O	Other	###	38	13.7	13.7	CD	CD	_	36	conj	_	_
%	NN	I-NP	O	Other	###	39	%	%	NN	NN	_	31	dep	_	_
;	:	O	O	Other	###	40	;	;	:	:	_	39	punct	_	_
P	NN	B-NP	O	Other	###	41	P	P	NN	NN	_	42	dep	_	_
<	SYM	B-NP	O	Other	###	42	<	<	SYM	SYM	_	39	dep	_	_
0.05	CD	I-NP	O	Other	###	43	0.05	0.05	CD	CD	_	42	nummod	_	_
)	)	O	O	Other	###	44	)	)	)	)	_	39	punct	_	_
.	.	O	O	Other	###	45	.	.	.	.	_	7	punct	_	_

Taken	VBN	B-VP	O	Other	###	1	Taken	Taken	VBN	VBN	_	6	advcl	_	_
together	RB	B-ADVP	O	Other	###	2	together	together	RB	RB	_	1	advmod	_	_
,	,	O	O	Other	###	3	,	,	,	,	_	6	punct	_	_
these	DT	B-NP	O	Other	###	4	these	these	DT	DT	_	5	det	_	_
results	NNS	I-NP	O	Other	###	5	results	results	NNS	NNS	_	6	nsubj	_	_
indicate	VBP	B-VP	O	Other	###	6	indicate	indicate	VBP	VBP	_	0	root	_	_
that	IN	B-SBAR	O	Other	###	7	that	that	IN	IN	_	13	mark	_	_
RA	NN	B-NP	B-cell_line	Other	###	8	RA	RA	NN	NN	_	13	nsubj	_	_
CD4	NN	B-NP	B-protein	B-Protein	###	9	CD4	CD4	NN	NN	_	8	dep	_	_
+	+	O	O	Other	###	10	+	+	+	+	_	9	cc	_	_
T	NN	I-NP	I-cell_line	Other	###	11	T	T	NN	NN	_	12	compound	_	_
cells	NNS	I-NP	I-cell_line	Other	###	12	cells	cells	NNS	NNS	_	9	conj	_	_
become	VBP	B-VP	O	Other	###	13	become	become	VBP	VBP	_	6	ccomp	_	_
less	RBR	B-ADJP	O	Other	###	14	less	less	RBR	RBR	_	15	advmod	_	_
susceptible	JJ	I-ADJP	O	Other	###	15	susceptible	susceptible	JJ	JJ	_	13	xcomp	_	_
to	TO	B-PP	O	Other	###	16	to	to	TO	TO	_	19	case	_	_
the	DT	B-NP	O	Other	###	17	the	the	DT	DT	_	19	det	_	_
immunoregulatory	JJ	I-NP	B-protein	Other	###	18	immunoregulatory	immunoregulatory	JJ	JJ	_	19	amod	_	_
effect	NN	I-NP	O	Other	###	19	effect	effect	NN	NN	_	15	nmod	_	_
of	IN	B-PP	O	Other	###	20	of	of	IN	IN	_	21	case	_	_
IL-10	NN	B-NP	B-protein	B-Protein	###	21	IL-10	IL-10	NN	NN	_	19	nmod	_	_
during	IN	B-PP	O	Other	###	22	during	during	IN	IN	_	25	case	_	_
the	DT	B-NP	O	Other	###	23	the	the	DT	DT	_	25	det	_	_
active	JJ	I-NP	O	Other	###	24	active	active	JJ	JJ	_	25	amod	_	_
phase	NN	I-NP	O	Other	###	25	phase	phase	NN	NN	_	19	nmod	_	_
.	.	O	O	Other	###	26	.	.	.	.	_	6	punct	_	_

